ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹27 Cr | ₹23 Cr | ₹20 Cr | ₹26 Cr | ₹32 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹27 Cr |
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹32 Cr |
How is Deferred Tax Assets / Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | 15.16 | |
| Mar2025 | ₹23 Cr | 16.96 | |
| Mar2024 | ₹20 Cr | -22.57 | |
| Mar2023 | ₹26 Cr | -18.68 | |
| Mar2022 | ₹32 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,278.2 Cr | 3.1% | -1.7% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 3.1% |
-1.7% |
-12.7% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses